MedKoo Cat#: 561038 | Name: MS-1020
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MS-1020 is a JAK3 and STAT3 inhibitor. MS-1020 potently inhibits persistently-active STAT3 in a cell type-specific manner. MS-1020 selectively blocks constitutively-active JAK3 and consistently suppressed interleukin-2-induced JAK3/STAT5 signalling.

Chemical Structure

MS-1020
MS-1020
CAS#1255516-86-9

Theoretical Analysis

MedKoo Cat#: 561038

Name: MS-1020

CAS#: 1255516-86-9

Chemical Formula: C21H18N2O3

Exact Mass: 346.1317

Molecular Weight: 346.39

Elemental Analysis: C, 72.82; H, 5.24; N, 8.09; O, 13.86

Price and Availability

Size Price Availability Quantity
5mg USD 250.00
25mg USD 620.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
MS-1020; MS 1020; MS1020
IUPAC/Chemical Name
1-Hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-2-naphthalenecarboxamide
InChi Key
KHJNISGKGIHTMY-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H18N2O3/c24-15-6-8-19-18(11-15)14(12-23-19)9-10-22-21(26)17-7-5-13-3-1-2-4-16(13)20(17)25/h1-8,11-12,23-25H,9-10H2,(H,22,26)
SMILES Code
O=C(C1=CC=C2C=CC=CC2=C1O)NCCC3=CNC4=C3C=C(O)C=C4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
MS-1020 is a potent and ATP-competitive JAK3 inhibitor.
In vitro activity:
MS-1020 potently inhibited persistently-active STAT3 in a cell type-specific manner. Further examination showed that MS-1020 selectively blocked constitutively-active JAK3 and consistently suppressed interleukin-2-induced JAK3/STAT5 signalling but not prolactin-induced JAK2/STAT5 signalling. Furthermore, MS-1020 affected cell viability only in cancer cells harbouring persistently-active JAK3/STATs, and in vitro kinase assays showed MS-1020 binds directly with JAK3, blocking its catalytic activity. Reference: Br J Haematol. 2010 Jan;148(1):132-43. https://pubmed.ncbi.nlm.nih.gov/19793252/
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 346.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
Kim BH, Oh SR, Yin CH, Lee S, Kim EA, Kim MS, Sandoval C, Jayabose S, Bach EA, Lee HK, Baeg GH. MS-1020 is a novel small molecule that selectively inhibits JAK3 activity. Br J Haematol. 2010 Jan;148(1):132-43. doi: 10.1111/j.1365-2141.2009.07925.x. Epub 2009 Sep 29. PMID: 19793252; PMCID: PMC3034357.
In vitro protocol:
Kim BH, Oh SR, Yin CH, Lee S, Kim EA, Kim MS, Sandoval C, Jayabose S, Bach EA, Lee HK, Baeg GH. MS-1020 is a novel small molecule that selectively inhibits JAK3 activity. Br J Haematol. 2010 Jan;148(1):132-43. doi: 10.1111/j.1365-2141.2009.07925.x. Epub 2009 Sep 29. PMID: 19793252; PMCID: PMC3034357.
In vivo protocol:
TBD
1: Kim BH, Oh SR, Yin CH, Lee S, Kim EA, Kim MS, Sandoval C, Jayabose S, Bach EA, Lee HK, Baeg GH. MS-1020 is a novel small molecule that selectively inhibits JAK3 activity. Br J Haematol. 2010 Jan;148(1):132-43. doi: 10.1111/j.1365-2141.2009.07925.x. Epub 2009 Sep 29. PubMed PMID: 19793252; PubMed Central PMCID: PMC3034357. 2: Sinclair CT, Kalender-Rich JL, Griebling TL, Porter-Williamson K. Palliative Care of Urologic Patients at End of Life. Clin Geriatr Med. 2015 Nov;31(4):667-78. doi: 10.1016/j.cger.2015.07.002. Review. PubMed PMID: 26476123. 3: Lemon RN, Mantel GW. The influence of changes in discharge frequency of corticospinal neurones on hand muscles in the monkey. J Physiol. 1989 Jun;413:351-78. PubMed PMID: 2600855; PubMed Central PMCID: PMC1189105. 4: Carmody J, Pawlak M, Messlinger K. Lack of a role for substance P in the control of dural arterial flow. Exp Brain Res. 1996 Oct;111(3):424-8. PubMed PMID: 8911936. 5: Buljubasich R, Ventura S. Adenosine 5'-triphosphate and noradrenaline are excitatory cotransmitters to the fibromuscular stroma of the guinea pig prostate gland. Eur J Pharmacol. 2004 Sep 24;499(3):335-44. PubMed PMID: 15381056. 6: Olschewski A, Bräu ME, Hempelmann G, Vogel W, Safronov BV. Differential block of fast and slow inactivating tetrodotoxin-sensitive sodium channels by droperidol in spinal dorsal horn neurons. Anesthesiology. 2000 Jun;92(6):1667-76. PubMed PMID: 10839918. 7: Kurosawa M, Messlinger K, Pawlak M, Schmidt RF. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol. 1995 Apr;114(7):1397-402. PubMed PMID: 7606344; PubMed Central PMCID: PMC1510285. 8: Armour JA, Janes RD. Neuronal activity recorded extracellularly from in situ canine mediastinal ganglia. Can J Physiol Pharmacol. 1988 Feb;66(2):119-27. PubMed PMID: 3370543. 9: Brock JW, Joshua IG. Neural release of substance P causes dilation of arterioles in rat striated muscle. Regul Pept. 1993 Jan 22;43(1-2):65-71. PubMed PMID: 7678938.